少年四大名捕（全文在线阅读）>
少年四大名捕Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_我的网站
A | Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。 妙语展风采 故事润童心 品华学校开展儿童故事大王比赛活动 故事是五彩的万花筒，是孩子世界的缩影。
B | 它伴随着孩子们的成长，给他们带来了无限的想象和幸福。
C | 为落实“品正 尚文”办学理念，营造良好的书香校园氛围，激发学生的阅读兴趣，培养良好的阅读习惯，提高对语言的感受能力和表达能力，品华学校于12月17日下午开展了“品真阅读节”暨阅读特色学校建设之“152•尚文阅读课程”系列活动儿童故事大王比赛，学校行政以及1-3年级师生共计350余人参加了本次活动。 刘瑶老师主持活动 小选手们个个精神饱满，信心十足，用稚嫩的声音自信地讲着自己精心准备的故事。他们的表演生动有趣，表情丰富，语调富有变化，让观众们仿佛“声”临其境。 1号选手 《在牛肚子里旅行》 2号选手 《卖火柴的小女孩》 3号选手 《愚公移山》 4号选手 《雪孩子》 5号选手 《老虎拔牙》 6号选手 《小猪种玉米》 7号选手 《鸡毛信》 8号选手 《小猪的理想》 9号选手 《小熊拔牙》 10号选手 《聪明的乌龟》 教务副主任龙扩大老师对本次活动进行了点评：他首先对筹备本次活动辛勤付出的老师们表示感谢，再为参赛的小选手们表示热烈的祝贺，并指出了每个节目呈现出来的亮点以及提出几点建议，鼓励同学们多阅读，从书中收获更多的知识与快乐。 教务副主任龙扩大老师进行活动点评 党支部书记、校长李润华老师对本次活动进行了总结：他向所有勇敢站上舞台的小选手们致以最崇高的敬意，并感谢辛勤付出的老师们以及每一位在场的家长和观众，最后祝愿每一位同学都能成为自己故事里的英雄，勇敢地书写属于自己的精彩篇章。 党支部书记、校长李润华老师进行活动总结 经过热情的角逐，评委们根据小选手们的综合表现，分别评选出一等奖、二等奖、三等奖。学校行政为他们颁奖并合影留念。本次讲故事比赛活动在热烈的颁奖仪式中画上了圆满的句号。 党支部书记、校长李润华老师为一等奖获奖同学代表颁奖 公派第一书记郁仁平老师为二等奖获奖同学代表颁奖 教务主任尚宏慧老师为三等奖获奖同学代表颁奖 通过此次讲故事比赛活动，同学们的语言表达能力得到了提升，更重要的是，大家见证了他们对生活的观察、对情感的细腻感知以及对美好事物的向往。故事，不仅仅是文字的堆砌，它是心灵的桥梁，它教会同学们善良、勇敢、坚持与爱，让他们在成长的路上不再孤单。
D | END 图文：小学语文科组 责任编辑：袁思思 一审一校：钟子英 二审二校：龙扩大 三审三校：尚宏慧 意见反馈 欢迎各位家长为我校提出宝贵的建议 电子邮箱 [email protected]反馈 或长按上面二维码识别，反馈建议。 2025年春季学期招生简章 我校已正式启动2025年春季学期招生工作，如您有意为孩子报读我校，请点击下面2025年春季学期招生简章链接，详细了解招生信息，致电我校招生办，或通过扫码下面“招生咨询号”微信，我们将在第一时间与您取得联系。 2025年春季学期招生简章 东莞市茶山品华学校2025年春季招生简章 东莞市茶山品华学校官方微信 尚雅的校园环境 | 优良的教学品质 | 贴心的教育服务 点击图片识别二维码 全方位了解东莞市品华学校 咨询电话：13728360936 东莞市品华学校 微信订阅号 东莞市品华学校 微信视频号 东莞品华学校 招生咨询号。
E | Current article:http://3eg.cousizhegaobaolengkuo.bond/l0ygb1/s33g.html Published on:20:31:22 |
